What will you learn?
The integration of high-throughput sequencing data in antibody screening accelerates and improves discovery of novel therapeutics and vaccines. Watch this presentation to discover how to leverage NGS data and structural liability analysis in your research. You will learn how to:
- Perform advanced clustering and phylogenetic analysis, independently and efficiently through an intuitive UI
- De-risk antibody candidate development by annotating structural liabilities for thousands of sequences
- Speed up candidate selection by exploring multiple antibody characteristics in a single visualization